Unknown

Dataset Information

Albumin-Binding Aptamer Chimeras for Improved siRNA Bioavailability.


ABSTRACT:

Introduction

Short interfering RNAs (siRNAs) are potent nucleic acid-based drugs designed to target disease driving genes that may otherwise be undruggable with small molecules. However, therapeutic potential of siRNA in vivo is limited by poor pharmacokinetic properties, including rapid renal clearance and nuclease degradation. Backpacking on natural carriers such as albumin, which is present at high concentration and has a long half-life in serum, is an effective way to modify pharmacokinetics of biologic drugs that otherwise have poor bioavailability. In this work, we sought to develop albumin-binding aptamer-siRNA chimeras to improve the bioavailability of siRNA.

Methods

A Systematic Evolution of Ligands through Exponential Enrichment (SELEX) approach was used to

SUBMITTER: Rosch JC 

PROVIDER: S-EPMC8938549 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature